{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-24-000046","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.837324+00:00","generated_at":"2026-05-30T05:27:17.831202+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sotera Health Q3 net rev $285M (+8.5% YoY); net income $17M vs loss $14M; reaffirms FY outlook","bullets":["Q3 net revenues $285M, up 8.5% YoY (8.9% constant currency); net income $17M ($0.06 diluted) vs net loss $14M in Q3 2023.","Adjusted EBITDA $146M, +9.0% YoY; Adjusted EPS $0.17, +$0.01 YoY.","Nine-month 2024 net revenues $810M (+9.6% YoY); net income $32M ($0.11 diluted) vs $13M prior year.","Reaffirming 2024 net revenue and Adjusted EBITDA outlook ranges.","CEO cites Nordion cobalt-60 timing benefit; investor day planned for Nov 20, 2024 in NYC."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-24-000046","json":"https://secwatch.observer/filing/0001822479-24-000046.json","markdown":"https://secwatch.observer/filing/0001822479-24-000046.md","text":"https://secwatch.observer/filing/0001822479-24-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/0001822479-24-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/shc-20241105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:27:17.831202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}